These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 16923407

  • 1. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
    Van Gelder IC, Van Veldhuisen DJ, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Bosker HA, Cornel JH, Kamp O, Veeger NJ, Volbeda M, Rienstra M, Ranchor AV, TenVergert EM, Van den Berg MP.
    Am Heart J; 2006 Sep; 152(3):420-6. PubMed ID: 16923407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 5. Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
    Groenveld HF, Tijssen JG, Crijns HJ, Van den Berg MP, Hillege HL, Alings M, Van Veldhuisen DJ, Van Gelder IC, RACE II Investigators.
    J Am Coll Cardiol; 2013 Feb 19; 61(7):741-8. PubMed ID: 23410544
    [Abstract] [Full Text] [Related]

  • 6. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM.
    Am J Cardiol; 2007 May 01; 99(9):1252-7. PubMed ID: 17478153
    [Abstract] [Full Text] [Related]

  • 7. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH, Capucci A, Fain E, Gold MR, van Gelder IC, Healey J, Israel CW, Lau CP, Morillo C, Connolly SJ, ASSERT Investigators and Committees.
    Am Heart J; 2006 Sep 01; 152(3):442-7. PubMed ID: 16923410
    [Abstract] [Full Text] [Related]

  • 8. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
    Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJ, RACE and AFFIRM Investigators.
    Europace; 2006 Nov 01; 8(11):935-42. PubMed ID: 16973686
    [Abstract] [Full Text] [Related]

  • 9. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G, Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
    Am Heart J; 2008 Sep 01; 156(3):520-6. PubMed ID: 18760135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI).
    Gold MR, Hoffmann E, SAFARI Investigators.
    Am Heart J; 2006 Aug 01; 152(2):231-6. PubMed ID: 16875902
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Roy D.
    Card Electrophysiol Rev; 2003 Sep 01; 7(3):208-10. PubMed ID: 14739714
    [Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.
    Am J Cardiol; 1997 May 01; 79(9):1198-202. PubMed ID: 9164885
    [Abstract] [Full Text] [Related]

  • 16. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M, Mangiameli S, Chiarandà G, Spadola V, Di Giovanni N, Colletti A, Bulla V, Circo A, Pensabene O, Vasquez L, Vaccaro I, Grammatico A, PITAGORA Study Investigators.
    Europace; 2006 Apr 01; 8(4):302-5. PubMed ID: 16627459
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Who, when and how to rate control for atrial fibrillation.
    Rienstra M, Van Gelder IC.
    Curr Opin Cardiol; 2008 Jan 01; 23(1):23-7. PubMed ID: 18281823
    [Abstract] [Full Text] [Related]

  • 19. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, Van Gelder IC, RACE Investigators.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1298-306. PubMed ID: 16198847
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.